Pharmaceutical giant AbbVie Inc. said it was re-evaluating its planned $54 billion acquisition of Shire PLC in light of new U.S. rules making it harder for American companies to lower taxes through overseas deal making.. The rethink is the most dramatic fallout so far from a broad crackdown by Washington on so-called inversionsâ€”takeover deals structured to relocate tax domiciles of U.S. companies overseas to capture tax benefits. 